Compare RZLT & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | IBEX |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 489.1M |
| IPO Year | N/A | 2020 |
| Metric | RZLT | IBEX |
|---|---|---|
| Price | $2.76 | $37.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $9.14 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 6.6M | 87.3K |
| Earning Date | 02-11-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.76 |
| EPS | N/A | ★ 2.77 |
| Revenue | N/A | ★ $579,735,000.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | N/A | $5.68 |
| P/E Ratio | ★ N/A | $13.76 |
| Revenue Growth | N/A | ★ 12.86 |
| 52 Week Low | $1.07 | $21.20 |
| 52 Week High | $11.46 | $42.99 |
| Indicator | RZLT | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 52.49 |
| Support Level | $2.36 | $37.26 |
| Resistance Level | $2.92 | $39.24 |
| Average True Range (ATR) | 0.27 | 1.21 |
| MACD | 0.32 | -0.07 |
| Stochastic Oscillator | 84.91 | 56.85 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.